Cardiac resynchronization therapy in non-ischemic cardiomyopathy: a comparative non-randomized study of His Bundle

Pablo Moriña-Vázquez1, María Teresa Moraleda-Salas2, Adrián Rodríguez-Albarrán3

  • 1Arrhythmia Unit, Department of Cardiology, Hospital Juan Ramon Jimenez (HJRJ)), Ronda Exterior Norte s/n. 21005, Huelva, Spain.

Insights

Permanent His bundle pacing cardiac resynchronization therapy (pHBP-CRT) significantly improved left ventricular ejection fraction (LVEF) more than classic biventricular pacing CRT. Pacing thresholds were similar between the two CRT methods.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Cardiac resynchronization therapy (CRT) is crucial for heart failure management.
  • Permanent His bundle pacing (pHBP) is an emerging CRT technique.
  • Limited comparative data exists between pHBP-CRT and classic biventricular pacing (BVP).

Purpose of the Study:

  • To compare the efficacy of pHBP-CRT versus classic CRT in improving left ventricular ejection fraction (LVEF).
  • To evaluate pacing thresholds and QRS duration in both CRT modalities.

Main Methods:

  • Single-center study comparing prospective pHBP-CRT (52 patients) with historical classic CRT (51 patients).
  • Included patients with non-ischemic cardiomyopathy, LVEF < 35%, and left bundle branch block (LBBB).

Main Results:

  • pHBP-CRT demonstrated superior LVEF improvement compared to classic CRT (median 55% vs. 40% at follow-up, p=0.001).
  • Pacing thresholds were similar between pHBP-CRT and classic CRT (p=0.48).
  • Median paced QRS duration was comparable between groups (135 ms vs. 140 ms, p=0.586).

Conclusions:

  • pHBP-CRT offers superior LVEF improvement over classic CRT.
  • Both pacing techniques show similar long-term thresholds and QRS narrowing.
  • pHBP-CRT is a promising alternative for CRT.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
44
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.0K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
772
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
61
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
130